Related Experiment Video
Updated: Jul 14, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device
Richard S Schofield1, Gary L Pierce, Wilmer W Nichols
1Department of Veterans Affairs Medical Center, Gainesville, Florida, USA. schofrs@medicine.ufl.edu
Insights
Left-ventricular assist device (LVAD) therapy increases central arterial pulse-wave reflections in heart failure patients, raising aortic augmented pressure and augmentation index. This hemodynamic load impacts LVAD management and device longevity.
Area of Science:
- Cardiology
- Biomedical Engineering
- Hemodynamics
Background:
- Chronic heart failure (HF) is linked to elevated central arterial pulse-wave reflections, potentially increasing myocardial oxygen demand.
- Left-ventricular assist device (LVAD) therapy is a common treatment for HF, but its impact on arterial pulse-wave reflections remains unstudied.
Purpose of the Study:
- To investigate the effects of LVAD support on central arterial pulse-wave reflections in patients with end-stage heart failure.
- To compare pulse-wave analysis data between LVAD patients, patients on inotropic drugs, and healthy controls.
Main Methods:
- Central aortic pulse-wave analysis was conducted using the SphygmoCor system.
- Data were collected from five end-stage HF patients on LVAD support, ten patients on intravenous inotropic drugs, and ten healthy controls.
Main Results:
- LVAD patients exhibited higher aortic augmented pressure and augmentation index (AI(a)) compared to inotropic and control groups.
- The AI(a) was significantly higher in LVAD patients (28.2%) versus inotropic patients (7.9%).
- LVAD patients showed a significantly higher aortic systolic tension time index, indicating increased myocardial oxygen demand.
Conclusions:
- LVAD support increases central arterial pulse-wave reflection in end-stage HF patients, elevating aortic augmented pressure and AI(a).
- The elevated AI(a) in LVAD patients compared to healthy controls suggests a significant hemodynamic alteration.
- Increased arterial wave reflection imposes a hemodynamic load on LVADs, potentially affecting device management and longevity.
Background:
Chronic heart failure (HF) is associated with increased central arterial pulse-wave reflections, which may contribute to increased myocardial oxygen demand. Although the treatment of HF via left-ventricular assist device (LVAD) placement has recently become widespread, the effects of LVAD therapy on central arterial pulse-wave reflections are unknown.
Methods:
Central aortic pulse-wave analysis was performed on patients with end-stage HF awaiting cardiac transplantation and on healthy age-matched controls using the SphygmoCor (Akor Medical, Sydney, Australia) system. Arterial pulse-wave data were compared between patients receiving LVAD support versus those receiving intravenous inotropic drugs and healthy control patients.
Results:
Five patients on LVAD support were compared with 10 patients on inotropic drugs and 10 healthy control patients. Aortic augmented pressure and the aortic augmentation index (AI(a)) were higher in LVAD patients compared with inotrope and control patients, despite similar brachial and aortic blood pressures between groups. The AI(a) was significantly higher in LVAD patients than in patients on inotropic drugs (28.2% +/- 10% v 7.9% +/- 9%, P < or = .01). Additionally, there was a significantly higher aortic systolic tension time index, an index of left-ventricular myocardial oxygen demand, in the LVAD group compared with the inotrope group (2655 +/- 298 mm Hg/sec/min v 1748 +/- 303 mm Hg/sec/min, P < .01).
Conclusions:
Central arterial pressure-wave reflection is increased in end-stage HF patients on LVAD support compared with those on inotropic drugs, leading to an increase in aortic augmented pressure, AI(a), and systolic tension time index. The AI(a) is also higher in LVAD patients than in healthy controls. This increased central arterial-wave reflection places an additional hemodynamic load on the LVAD device and may have relevance to the medical management of patients after LVAD placement and to the longevity of the LVAD device itself.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction